The implementation of endovascular therapy as a treatment for acute ischemic stroke has developed greatly in recent years. The primary trials demonstrated negative to mixed results, and it wasn't until the MR CLEAN trial that thrombectomy was established as a beneficial treatment. Since then, further studies have continued to provide additional data allowing for expansion of patient eligibility to receive such therapy. This manuscipt highlights the development and progression of the utilization of endovascular treatment in acute ischemic stroke.
Lee et al. (Thu,) studied this question.